Evidence map›Paper›PMID 33165406›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2020

[Microcephaly and central nervous system findings associated with congenital Zika virus and other infectious etiologies in the state of Rio de Janeiro: crosssectional study, 2015 a 2017Microcefalia y alteraciones del sistema nervioso central relacionadas con la infección congénita por el virus del Zika y otras etiologías infecciosas en el Estado de Río de Janeiro: estudio transversal, 2015-2017].

Claudia Caminha Escosteguy, Renata Escosteguy Medronho, Renata Coelho Rodrigues, Lucas Dalsenter Romano da Silva, Bruna Andrade de Oliveira, Fernanda Beatriz Machado, Yuri Sousa Costa, Silvia Cristina de Carvalho Cardoso, Antonio José Ledo Alves da Cunha, Roberto de Andrade Medronho

Open access · diamondAbstract readEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Claudia Caminha EscosteguyHospital Federal dos Servidores do Estado Serviço de Epidemiologia Rio de Janeiro (RJ) Brasil Hospital Federal dos Servidores do Estado, Serviço de Epidemiologia, Rio de Janeiro (RJ), Brasil.
Renata Escosteguy MedronhoUniversidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina Serviço de Epidemiologia Rio de Janeiro (RJ) Brasil Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Rio de Janeiro (RJ), Brasil.
Renata Coelho RodriguesUniversidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina Serviço de Epidemiologia Rio de Janeiro (RJ) Brasil Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Rio de Janeiro (RJ), Brasil.
Lucas Dalsenter Romano da SilvaUniversidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina Serviço de Epidemiologia Rio de Janeiro (RJ) Brasil Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Rio de Janeiro (RJ), Brasil.
Bruna Andrade de OliveiraUniversidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina Serviço de Epidemiologia Rio de Janeiro (RJ) Brasil Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Rio de Janeiro (RJ), Brasil.
Fernanda Beatriz MachadoUniversidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina Serviço de Epidemiologia Rio de Janeiro (RJ) Brasil Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Rio de Janeiro (RJ), Brasil.
Yuri Sousa CostaUniversidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina Serviço de Epidemiologia Rio de Janeiro (RJ) Brasil Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Rio de Janeiro (RJ), Brasil.
Silvia Cristina de Carvalho CardosoSecretaria de Estado de Saúde do Rio de Janeiro Brasil Secretaria de Estado de Saúde do Rio de Janeiro, Brasil.
Antonio José Ledo Alves da CunhaUniversidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina Serviço de Epidemiologia Rio de Janeiro (RJ) Brasil Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Rio de Janeiro (RJ), Brasil.
Roberto de Andrade MedronhoUniversidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Instituto de Estudos em Saúde Rio de Janeiro Brasil Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Instituto de Estudos em Saúde, Rio de Janeiro (RJ), Brasil.
Hospital Roberto del Rio · CLSecretaria da Saúde · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe the clinical and epidemiological profile of cases with confirmed microcephaly or central nervous system (CNS) findings associated with congenital Zika virus infection and other infectious etiologies in the state of Rio de Janeiro, Brazil, from November 2015 to July 2017.

methodA cross-sectional study was performed with 298 cases (as defined by the Ministry of Health) communicated to the Rio de Janeiro State Department of Health in the study period. Demographic, epidemiological, clinical, radiological, and laboratory variables were assessed. Descriptive bivariate and multivariable logistic regression analysis was used to determine the association between specific factors and death outcome.

resultsThe median age of mothers was 24 years; 30.9% reported fever and 64.8% reported a rash during pregnancy. The median head circumference at birth was 29 cm, and median birth weight was 2 635 g. An etiological diagnosis of congenital Zika was made in 46.0%, whereas 13.8% were diagnosed with syphilis, toxoplasmosis, rubella, cytomegalovirus, and herpes simplex infections (STORCH), with predominance of syphilis, and 40.3% had an unspecified infectious agent. CNS findings other than microcephaly were observed in 88.3%, especially intracranial calcifications, ventriculomegaly, and brain atrophy. Overall lethality was 7.0% - 19.0% in laboratory confirmed Zika cases and 22.2% in toxoplasmosis cases. Multivariable analysis revealed birth weight as the main predictor of death.

conclusionsDespite the Zika epidemic, 13.8% of the studied cases were diagnosed with STORCH. The lethality and high frequency of neurological findings beyond microcephaly reflect severe infection, with impact on families and health care system.

Indexed as

Brazilcongenital abnormalitiesepidemicsepidemiologymicrocephalyZika virus

Identifiers

PMID33165406
PMCPMC7609916
OpenAlexW3096582811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.